Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350]. (March 2022)

Record Type:: Journal Article
Title:: Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350]. (March 2022)
Main Title:: Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350]
Authors:: Friedlaender, Alex
Naidoo, Jarushka
Luigi Banna, Giuseppe
Metro, Giulio
Forde, Patrick
Addeo, Alfredo
Abstract:
Is Part Of:: Cancer treatment reviews. Volume 104(2022)
Journal:: Cancer treatment reviews
Issue:: Volume 104(2022)
Issue Display:: Volume 104, Issue 2022 (2022)
Year:: 2022
Volume:: 104
Issue:: 2022
Issue Sort Value:: 2022-0104-2022-0000
Page Start:
Page End:
Publication Date:: 2022-03
Subjects:: Cancer -- Periodicals
Cancer -- Treatment -- Periodicals
Neoplasms -- therapy -- Periodicals
Cancer -- Périodiques
Cancer -- Traitement -- Périodiques
Cancer -- Treatment
Electronic journals
Periodicals
616.99406
Journal URLs:: http://www.sciencedirect.com/science/journal/03057372 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.ctrv.2022.102358 ↗
Languages:: English
ISSNs:: 0305-7372
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3046.630000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21136.xml